Patent application number | Description | Published |
20090154663 | SELF-PROVISIONING, NOTIFICATION, RETRIEVAL, AND SUBMISSION OF VISUAL VOICE MAIL - A method includes receiving from a visual voice mail (VVM) client a request to access VVM services and determining whether VVM services have been previously activated. The method further includes providing a negative response to the VVM client if it is determined that VVM services have not been activated and receiving, from the VVM client, a self-provisioning request to initialize VVM services. The method may also include configuring VVM services based on the self-provisioning request and providing, to the VVM client, an indication that VVM services have been configured. The method may additionally include providing notifications and retrieval of voice mail messages, and submitting voice mail messages from the user device. | 06-18-2009 |
20090156176 | VISUAL VOICEMAIL PROVISIONING AND NOTIFICATION - A device receives, from a user device, a request to use a visual voicemail (VVM) application, directs the user device to a self provisioning server based on the request, and receives, from the self provisioning server, a selected VVM subscription plan and information associated with a user of the user device. The device also provides, to a billing system, a feature code associated with the selected VVM subscription plan, receives, from one or more voicemail servers, pre-existing voicemail messages associated with the user, and provides, to the user device, the pre-existing voicemail messages. | 06-18-2009 |
20090319848 | PROVISIONING DEVICE MAKE AND MODEL INFORMATION FOR FIRMWARE OVER-THE-AIR (FOTA) - A device receives identifier, make, and model information associated with a device from a device activation system, and provides the device identifier, make, and model information to a database. The device also determines whether the device qualifies for a software update package based on the device make and model information, and provides, to the device, a notification of the software update package when the device qualifies for the software update package. | 12-24-2009 |
20120163567 | VISUAL VOICEMAIL PROVISIONING AND NOTIFICATION - A device receives, from a user device, a request to use a visual voicemail (VVM) application, directs the user device to a self provisioning server based on the request, and receives, from the self provisioning server, a selected VVM subscription plan and information associated with a user of the user device. The device also provides, to a billing system, a feature code associated with the selected VVM subscription plan, receives, from one or more voicemail servers, pre-existing voicemail messages associated with the user, and provides, to the user device, the pre-existing voicemail messages. | 06-28-2012 |
20130157622 | SYSTEMS AND METHODS FOR PROVIDING MOBILE HANDSET POSITION TO SOFTWARE APPLICATIONS - Providing information as to location of a mobile station involves receiving a mobile station location request from a requesting software application at an API gateway of a wireless communications network. The API gateway provides a network-initiated request to the wireless communications network for the location of the mobile station after determining that the requesting application is authorized to receive the location of the specified mobile station. The location of the mobile station can be determined, according to either a coarse or granular location position resolution, or accuracy, based on the request of the application and/or the conditions of the wireless communication network. Information as to location of the mobile station can be produced, and provided to the requesting software application, which can be resident on the mobile station itself or at a different location/platform. | 06-20-2013 |
20140073355 | TRUSTED MODE LOCATION SERVICE FOR MOBILE DEVICE ACCESS TO PRIVATE NETWORK BASED APPLICATIONS - In response to a location assistance request initiated by a mobile device on a private network and directed to a data access port of a location server in a public mobile communication network, a source network address is extracted from the received request. If the extracted source network address is determined to be associated with a trusted private network domain, location assistance data obtained by the location server is provided to the mobile device on the private network without requiring any proprietary messaging schemes or application-specific authentication credentials. | 03-13-2014 |
Patent application number | Description | Published |
20080300408 | Process for Preparing a Pure Polymorphic Form of 3-Pyridyl-1-Hydroxyethylidine-1, 1-Bisphosphonic Acid Sodium Salt - This process in general relates to the novel process for preparing polymorphic forms of 3-pyridyl-1-hydroxyethylidine-1,1-bisphosphonic acid sodium salt (Risedronate Sodium) in particular risedronate Form A and B employing a solvent system in an appropriate ratio. An improved process for preparation of risedronic acid is also disclosed in the present invention. | 12-04-2008 |
20090005556 | Process for Producing Pure Form of 2-Methyl-4-(4-Methyl-1-Piperazinyl)-10H-Thieno[2,3-b] [1,5]Benzodiazepine - Disclosed is a process for producing pure form of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine. The process comprises of reacting 2-(2-aminoanilino)-5-methylthiophene-3-carbonitrile with N-methyl piperazine in conjunction with N-methylpiperazine acid salt, to produce 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine. Also disclosed is a process for obtaining the Polymorphic Form I of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine by crystallizing the crude 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine in a mixture of solvents. | 01-01-2009 |
20090312551 | Process for producing biphosphonic acids and forms thereof - Disclosed herein is a process for producing bisphosphonic acids and salts thereof. The process comprising reacting a carboxylic acid of Formula [I] with phosphorous acid and halophosphorus compound in the presence of a solvent selected from aliphatic hydrocarbon or water miscible cyclic ether. Further, the present invention also provides novel forms of bisphosphonic acids and process for preparation thereof. | 12-17-2009 |
20110046396 | POLYMORPHIC FORMS OF FLUVASTATIN SODIUM AND PROCESS FOR PREPARING THE SAME - Disclosed herein are novel polymorphic forms of Fluvastatin sodium, wherein said polymorphic forms are designated as J | 02-24-2011 |
Patent application number | Description | Published |
20120190849 | PROCESSES FOR THE PREPARATION OF VARDENAFIL - The present invention provides processes for the preparation of vardenafil, its pharmaceutically acceptable salts, hydrates and intermediates. | 07-26-2012 |
20120220777 | PROCESS FOR THE PREPARATION OF A CRYSTALLINE FORM OF LENALIDOMIDE - The present invention relates to an in-situ process for the preparation of polymorphic Form A of lenalidomide. | 08-30-2012 |
20120220783 | SALTS OF SUNITINIB - The present invention relates to salts of sunitinib and their preparation. | 08-30-2012 |
20120264789 | POLYMORPHS OF SORAFENIB ACID ADDITION SALTS - The present invention provides amorphous and crystalline forms of acid addition salts of sorafenib, pharmaceutical compositions comprising them and their use for the treatment of cancer. The present invention also provides processes for the preparation of acid addition salts of sorafenib. | 10-18-2012 |
20120271056 | PROCESS FOR THE PREPARATION OF CRYSTALLINE FORM I OF L-MALIC ACID SALT OF SUNITINIB - The present invention relates to a process for the preparation of crystalline Form I of the L-malic acid salt of sunitinib. | 10-25-2012 |
20120283440 | CRYSTALLINE FORMS OF BOSENTAN SALTS AND PROCESSES FOR THEIR PREPARATION - The present invention relates to crystalline forms of bosentan salts and processes for their preparation.(FORMULA) | 11-08-2012 |
20120302749 | PROCESSES FOR THE PREPARATION OF ERLOTINIB HYDROCHLORIDE FORM A AND ERLOTINIB HYDROCHLORIDE FORM B - The present invention relates to processes for the preparation of erlotinib hydrochloride Form A and erlotinib hydrochloride Form B. (I). | 11-29-2012 |
20130005777 | SORAFENIB ETHYLSULFONATE SALT, PROCESS FOR PREPARATION AND USE - The present invention provides sorafenib ethane sulphonate, process for its preparation, pharmaceutical composition comprising sorafenib ethane sulphonate and its use for the treatment of cancer. Formula (III). | 01-03-2013 |
20130005980 | PROCESS FOR THE PREPARATION OF SORAFENIB TOSYLATE - The present invention provides a process for the preparation of sorafenib tosylate, comprising contacting sorafenib free base with p-toluenesulphonic acid in water. | 01-03-2013 |
20130123511 | PROCESS FOR THE DIRECT PREPARATION OF MALIC ACID SALT OF SUNITINIB - The present invention relates to a process for the direct preparation of malic acid salt of sunitinib. | 05-16-2013 |
20130197232 | PROCESS FOR THE PREPARATION OF CRYSTALLINE FORMS OF DEXLANSOPRAZOLE - The present invention relates to crystalline forms of dexlansoprazole designated as forms A and B, and their preparation. The present invention further relates to processes for the preparation of anhydrous dexlansoprazole and dexlansoprazole sesquihydrate using crystalline Forms A and B of dexlansoprazole. | 08-01-2013 |
20130197233 | SALTS OF DEXLANSOPRAZOLE AND THEIR PREPARATION - The present invention relates to the salts of dexlansoprazole in amorphous form. The present invention further relates to processes for the preparation of salts of dexlansoprazole. | 08-01-2013 |
20130204002 | PROCESS FOR THE PREPARATION OF DEXLANSOPRAZOLE - The present invention relates to a process for the preparation of crystalline dexlansoprazole. | 08-08-2013 |
20130210865 | SORAFENIB DIMETHYL SULPHOXIDE SOLVATE - The present invention provides dimethyl sulphoxide solvate of 4-(4-{3-[4-chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N | 08-15-2013 |
20130210885 | CRYSTALLINE FORMS OF L-MALIC ACID SALT OF SUNITINIB - The present invention relates to crystalline forms of L-malic acid salt of sunitinib and its preparation. The crystalline forms of the present invention are designated as Form V and Form VI of L-malic acid salt of sunitinib. Formula (I). | 08-15-2013 |
20130274478 | POLYMORPHS OF SORAFENIB ACID ADDITION SALTS - The present invention provides amorphous and crystalline forms of acid addition salts of sorafenib, pharmaceutical compositions comprising them, and their use for the treatment of cancer. The present invention also provides processes for the preparation of acid addition salts of sorafenib. | 10-17-2013 |
20140187568 | CRYSTALLINE FORMS OF BOSENTAN SALTS AND PROCESSES FOR THEIR PREPARATION - The present invention relates to crystalline forms of bosentan salts and processes for their preparation. | 07-03-2014 |
20140187569 | CRYSTALLINE FORMS OF BOSENTAN SALTS AND PROCESSES FOR THEIR PREPARATION - The present invention relates to crystalline forms of bosentan salts and processes for their preparation. | 07-03-2014 |
20140336380 | PROCESS FOR THE PREPARATION OF AGOMELATINE | 11-13-2014 |
20140343290 | PROCESS FOR THE PREPARATION OF ATAZANAVIR OR ITS BISULFATE SALT - The present invention relates to an improved process for the preparation of atazanavir bisulfate, an inhibitor of retroviral aspartate protease. The process of the present invention comprises conversion of 1,1-dimethylethyl[(2S,3R)-4-chloro-3-hydroxy-phenylbutan-2-yl]carbamate (Formula II) into 1-[4-(pyridine-2-yl)-phenyl]-4(S)-5 hydroxy-2-N-tert-butoxycarbonylamino-5(S)āNā(N-methoxycarbonyl-(L)-tert-leucyl)amino-6-phenyl-2-azahexane (Formula VII) without isolating intermediate compounds formed therein, followed by its subsequent conversion to atazanavir or its bisulfate salt. | 11-20-2014 |
20140357870 | PROCESS FOR THE PREPARATION OF DEXLANSOPRAZOLE - The present invention relates to a process for the preparation of dexlansoprazole.xH | 12-04-2014 |